Showing results (381-390 of 581) with videos related to

Sort By:
Pageof 59
ACS Chemical Neuroscience|December 11, 2025
Deep Proteome Profiling of Rat Dorsal Striatal Synaptoneurosomes Following Methamphetamine ExposureLaura G Rodriguez, F Javier Rubio, Megan A M Burke, et al.
Physics in Medicine and Biology|August 10, 2010
Determination of average LET of therapeutic proton beams using Al2O3:C optically stimulated luminescence (OSL) detectorsGabriel O Sawakuchi, Narayan Sahoo, Patricia B R Gasparian, et al.
Dementia and Geriatric Cognitive Disorders|February 15, 2001
Regional cerebral blood flow and prognostic evaluation in Alzheimer's diseaseF Nobili, F Copello, F Buffoni, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|December 1, 1979
In vitro activation of neutrophils by suspensions of Mycobacterium lepraeM Goihman-Yahr, G Rodriguez-Ochoa, N Aranzazu, et al.
Spinal Cord|March 1, 2017
Validation of the instrumented evaluation of spatio-temporal gait parameters in patients with motor incomplete spinal cord injuryA I Pérez-Sanpablo, J Quinzaños-Fresnedo, R Loera-Cruz, et al.
Spinal Cord|July 8, 2017
Validation of the instrumented evaluation of spatio-temporal gait parameters in patients with motor incomplete spinal cord injuryA I Pérez-Sanpablo, J Quinzaños-Fresnedo, R Loera-Cruz, et al.
Spine|January 5, 2007
Stab incision for inducing intervertebral disc degeneration in the ratMarc-Antoine A Rousseau, Jill A Ulrich, Elisa C Bass, et al.
Lupus|April 1, 1996
Accuracy of 133-xenon regional cerebral blood flow and quantitative electroencephalography in systemic lupus erythematosusF Nobili, G Rodriguez, A Arrigo, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|August 25, 2009
Biomimetic Ca-P coatings incorporating bisphosphonates produced on starch-based degradable biomaterialsA L Oliveira, A J Pedro, C Saiz Arroyo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusionH Burris, R Irvin, J Kuhn, et al.
Pageof 59